NCT06344728View on ClinicalTrials.gov

A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

May 24, 2024

Study Completion Date

May 24, 2024

Conditions

Healthy Participants

Interventions

DRUG

Brensocatib Oral Solution

Brensocatib solution

DRUG

Brensocatib Oral Tablet

Brensocatib tablet

Trial Locations (1)

75230

USA001, Dallas

All Listed Sponsors

lead

Insmed Incorporated

INDUSTRY